NCT06921174

Brief Summary

GA34.01 postpartum, a randomized design with a parallel group structure will be applied, randomly assigning participants into two groups. The first group will receive the traditional perineal massage therapy, while the second group will use the intravaginal device "Crescendo 2." In this study, a pre- and post-intervention evaluation will be conducted, using the Visual Analog Scale (VAS) as the primary outcome measure and the Clinical Global Impression Scale as the secondary outcome measure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2025

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

March 27, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 10, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

April 10, 2025

Status Verified

April 1, 2025

Enrollment Period

2 months

First QC Date

March 27, 2025

Last Update Submit

April 3, 2025

Conditions

Keywords

postpartum pelvic pain

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale (VAS) - to assess pain intensity

    The \*\*Visual Analogue Scale (VAS)\*\* will be used as the \*\*primary outcome measure\*\*. It consists of a horizontal line approximately 10 centimeters long. At each end of the line are the extreme expressions of pain: on the left, "no pain," and on the right, "worst imaginable pain." This tool allows us to measure the intensity of pain with high reproducibility between observers. Visual Analogue Scale (VAS): The Visual Analogue Scale is a psychometric response scale used to measure pain intensity. It typically consists of a 10-centimeter horizontal line anchored by two verbal descriptors: "no pain" (score = 0) and "worst imaginable pain" (score = 10). Minimum score: 0 (no pain) Maximum score: 10 (worst imaginable pain) Interpretation: Higher scores indicate worse outcomes (i.e., more intense pain).

    First measure week 1 and Last measure week 12

Secondary Outcomes (1)

  • Clinical Global Impression (CGI) - for overall health status

    At the end of the treatment week 12

Study Arms (2)

Classical Perineal Massage Therapy

ACTIVE COMPARATOR

Performed manually by a pelvic floor physiotherapist. One 30-minute session per week for 12 weeks.

Procedure: Classical Perineal Massage Therapy

Use of the "Crescendo 2" Intravaginal Device

EXPERIMENTAL

Self-administered perineal massage at home. Three times per week, 10 minutes each session, over a 12-week period.

Device: Use of the "Crescendo 2" Intravaginal Device

Interventions

Self-administered perineal massage at home with Crescendo device. Three times per week, 10 minutes each session, over a 12-week period.

Use of the "Crescendo 2" Intravaginal Device

Performed manually by a pelvic floor physiotherapist. One 30-minute session per week for 12 weeks.

Classical Perineal Massage Therapy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 18 years or older.
  • Residing in the Region of Murcia.
  • Having had a vaginal delivery between 6 weeks and 12 months prior to enrollment.
  • Presenting postpartum perineal pain, coded in ICD-11 as GA34.01.
  • Have not received any prior treatment for this condition.

You may not qualify if:

  • Presence of severe conditions such as:
  • Excessive postpartum hemorrhage
  • Serious infections
  • Respiratory or circulatory complications
  • Neurological disorders requiring intensive medical intervention
  • Currently under pharmacological treatment for pelvic pain.
  • Active vaginal infections.
  • Expressed refusal to participate or inability to comply with study procedures.
  • Women with episiotomy may participate only if there were no complications such as severe infection or hemorrhage following the procedure.
  • Willingness to participate and to follow the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Sexológico Murciano

Murcia, Murcia, 30007, Spain

RECRUITING

Related Publications (2)

  • Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet. 2002 Feb 9;359(9305):515-9. doi: 10.1016/S0140-6736(02)07683-3.

    PMID: 11853818BACKGROUND
  • Beckmann MM, Garrett AJ. Antenatal perineal massage for reducing perineal trauma. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005123. doi: 10.1002/14651858.CD005123.pub2.

    PMID: 16437520BACKGROUND

Related Links

MeSH Terms

Conditions

Pelvic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Jesús Eugenio Dr. Rodríguez Martínez, Phd

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Type: Randomized Controlled Trial (RCT) Structure: Two parallel groups (random assignment)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2025

First Posted

April 10, 2025

Study Start

March 27, 2025

Primary Completion

June 1, 2025

Study Completion

August 31, 2025

Last Updated

April 10, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Study Protocol Access

Locations